Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn's Disease.
Yoo Min LeeEun-Sil KimSujin ChoiHyo-Jeong JangYu Bin KimSo Yoon ChoiByung-Ho ChoeBen KangPublished in: Gut and liver (2023)
: Postinduction FC was associated with PR and EH after 1 year of treatment with IFX in pediatric patients with CD. Our findings emphasize the importance of FC as an intermediate target in the treat-to-target era.